Literature DB >> 24101059

More americans living longer with cardiovascular disease will increase costs while lowering quality of life.

Ankur Pandya, Thomas A Gaziano, Milton C Weinstein, David Cutler.   

Abstract

In the past several decades, some risk factors for cardiovascular disease have improved, while others have worsened. For example, smoking rates have dropped and treatment rates for cardiovascular disease have increased-factors that have made the disease less fatal. At the same time, Americans' average body mass index and incidence of diabetes have increased as the population continues to live longer-factors that have made cardiovascular disease more prevalent. To assess the aggregate impact of these opposing trends, we used the nine National Health and Nutrition Examination Survey waves from 1973 to 2010 to forecast total cardiovascular disease risk and prevalence from 2015 to 2030. We found that continued improvements in cardiovascular disease treatment and declining smoking rates will not outweigh the influence of increasing population age and obesity on cardiovascular disease risk. Given an aging population, an obesity epidemic, and declining mortality from the disease, the United States should expect to see a sharp rise in the health care costs, disability, and reductions in quality of life associated with increased prevalence of cardiovascular disease. Policies that target the treatment of high blood pressure and cholesterol and the reduction of obesity will be necessary to curb the imminent spike in cardiovascular disease prevalence.

Entities:  

Keywords:  Cardiovascular Disease; Obesity; Primary Prevention; Public Health; Tobacco/Smoking

Mesh:

Year:  2013        PMID: 24101059      PMCID: PMC3894660          DOI: 10.1377/hlthaff.2013.0449

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  40 in total

1.  Predicted impact of attaining smoking reduction goals on mortality.

Authors:  M D Silverstein; P J Nietert; J S Zoller; G A Silvestri
Journal:  South Med J       Date:  2001-02       Impact factor: 0.954

2.  US cardiologist workforce from 1995 to 2007: modest growth, lasting geographic maldistribution especially in rural areas.

Authors:  Sanjay Aneja; Joseph S Ross; Yongfei Wang; Masatoshi Matsumoto; George P Rodgers; Susannah M Bernheim; Saif S Rathore; Harlan M Krumholz
Journal:  Health Aff (Millwood)       Date:  2011-12       Impact factor: 6.301

3.  Forecasting the effects of obesity and smoking on U.S. life expectancy.

Authors:  Susan T Stewart; David M Cutler; Allison B Rosen
Journal:  N Engl J Med       Date:  2009-12-03       Impact factor: 91.245

4.  Forecasting the obesity epidemic in the aging U.S. population.

Authors:  Y Claire Wang; Graham A Colditz; Karen M Kuntz
Journal:  Obesity (Silver Spring)       Date:  2007-11       Impact factor: 5.002

5.  Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients.

Authors:  Giampiero Mazzaglia; Ettore Ambrosioni; Marianna Alacqua; Alessandro Filippi; Emiliano Sessa; Vincenzo Immordino; Claudio Borghi; Ovidio Brignoli; Achille P Caputi; Claudio Cricelli; Lorenzo G Mantovani
Journal:  Circulation       Date:  2009-10-05       Impact factor: 29.690

6.  Adolescent overweight and future adult coronary heart disease.

Authors:  Kirsten Bibbins-Domingo; Pamela Coxson; Mark J Pletcher; James Lightwood; Lee Goldman
Journal:  N Engl J Med       Date:  2007-12-06       Impact factor: 91.245

Review 7.  Social determinants and the decline of cardiovascular diseases: understanding the links.

Authors:  Sam Harper; John Lynch; George Davey Smith
Journal:  Annu Rev Public Health       Date:  2011       Impact factor: 21.981

8.  Explaining the decrease in U.S. deaths from coronary disease, 1980-2000.

Authors:  Earl S Ford; Umed A Ajani; Janet B Croft; Julia A Critchley; Darwin R Labarthe; Thomas E Kottke; Wayne H Giles; Simon Capewell
Journal:  N Engl J Med       Date:  2007-06-07       Impact factor: 91.245

Review 9.  Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies.

Authors:  M R Law; J K Morris; N J Wald
Journal:  BMJ       Date:  2009-05-19

10.  Changing population characteristics, effect-measure modification, and cancer risk factor identification.

Authors:  Martha L Slattery; Maureen A Murtaugh; Charles Quesenberry; Bette J Caan; Sandra Edwards; Carol Sweeney
Journal:  Epidemiol Perspect Innov       Date:  2007-10-01
View more
  22 in total

1.  Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease.

Authors:  Ankur Pandya; Stephen Sy; Sylvia Cho; Milton C Weinstein; Thomas A Gaziano
Journal:  JAMA       Date:  2015-07-14       Impact factor: 56.272

2.  Validation of a Cardiovascular Disease Policy Microsimulation Model Using Both Survival and Receiver Operating Characteristic Curves.

Authors:  Ankur Pandya; Stephen Sy; Sylvia Cho; Sartaj Alam; Milton C Weinstein; Thomas A Gaziano
Journal:  Med Decis Making       Date:  2017-05-10       Impact factor: 2.583

Review 3.  Health-related quality of life in coronary heart disease: a systematic review and meta-analysis mapped against the International Classification of Functioning, Disability and Health.

Authors:  Jana Le; Diana S Dorstyn; Elias Mpofu; Elise Prior; Phillip J Tully
Journal:  Qual Life Res       Date:  2018-05-19       Impact factor: 4.147

4.  Protecting the gains: What changes are needed to prevent a reversal of the downward cardiovascular disease mortality trend?

Authors:  Jesse D Ortendahl; Allison L Diamant; Peter P Toth; Dasha Cherepanov; Amanda L Harmon; Michael S Broder
Journal:  Clin Cardiol       Date:  2018-11-28       Impact factor: 2.882

5.  Association of the SPT2 chromatin protein domain containing 1 gene rs17579600 polymorphism and serum lipid traits.

Authors:  Tao Guo; Rui-Xing Yin; Yuan Bin; Rong-Jun Nie; Xia Chen; Shang-Ling Pan
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

6.  Cardiovascular Disease Projections in the United States Based on the 2020 Census Estimates.

Authors:  Reza Mohebi; Chen Chen; Nasrien E Ibrahim; Cian P McCarthy; Hanna K Gaggin; Daniel E Singer; Emily P Hyle; Jason H Wasfy; James L Januzzi
Journal:  J Am Coll Cardiol       Date:  2022-08-09       Impact factor: 27.203

7.  Simulated Effects of Policies to Reduce Diabetes Risk Among Adults With Schizophrenia Receiving Antipsychotics.

Authors:  Andrew W Mulcahy; Sharon-Lise Normand; John W Newcomer; Benjamin Colaiaco; Julie M Donohue; Judith R Lave; Emmett Keeler; Mark J Sorbero; Marcela Horvitz-Lennon
Journal:  Psychiatr Serv       Date:  2017-09-01       Impact factor: 3.084

8.  Improving cardiovascular health and metabolic comorbidities in patients with psoriatic arthritis.

Authors:  Alexis Ogdie; Lihi Eder
Journal:  Int J Clin Rheumtol       Date:  2015-12

9.  Effect of resistance training on neuromuscular junctions of young and aged muscles featuring different recruitment patterns.

Authors:  Michael R Deschenes; E Grace Sherman; Mackenzie A Roby; Emily K Glass; M Brennan Harris
Journal:  J Neurosci Res       Date:  2014-10-07       Impact factor: 4.164

10.  Predictors of Mortality in Older Adults With Epilepsy: Implications for Learning Health Systems.

Authors:  Leah J Blank; Emily K Acton; Allison W Willis
Journal:  Neurology       Date:  2020-10-21       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.